EP
Eversept Partners’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-92,909
| Closed | -$2.45M | – | 70 |
|
|
2024
Q2 | $2.45M | Sell |
92,909
-162,617
| -64% | -$4.29M | 0.17% | 60 |
|
|
2024
Q1 | $8.26M | Buy |
255,526
+141,733
| +125% | +$4.58M | 0.55% | 31 |
|
|
2023
Q4 | $4.79M | Buy |
+113,793
| New | +$4.79M | 0.42% | 37 |
|
|
2021
Q3 | – | Sell |
-110,183
| Closed | -$1.16M | – | 98 |
|
|
2021
Q2 | $1.16M | Sell |
110,183
-120,000
| -52% | -$1.27M | 0.08% | 60 |
|
|
2021
Q1 | $3.69M | Buy |
+230,183
| New | +$3.69M | 0.28% | 48 |
|
|
2020
Q3 | – | Sell |
-12,266
| Closed | -$299K | – | 57 |
|
|
2020
Q2 | $299K | Sell |
12,266
-64,600
| -84% | -$1.57M | 0.04% | 63 |
|
|
2020
Q1 | $1.2M | Hold |
76,866
| – | – | 0.3% | 35 |
|
|
2019
Q4 | $1.22M | Buy |
+76,866
| New | +$1.22M | 0.22% | 59 |
|